What does a blood test film comment indicating polychromasia, anisochromasia, and a few poikilocytes (irregularly shaped red blood cells) mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Film Findings: Polychromasia, Anisochromasia, and Poikilocytes

These findings indicate your bone marrow is actively producing new red blood cells (polychromasia) in response to anemia or blood loss, with variation in red cell color (anisochromasia) and some abnormally shaped cells (poikilocytes), requiring further investigation to determine the underlying cause.

What Each Finding Means

Polychromasia

  • Polychromasia refers to red blood cells that appear bluish-gray or purple on the blood film due to residual RNA in young red cells (reticulocytes) 1
  • This indicates active bone marrow response and increased red blood cell production, which is seen in hemolytic anemia, acute blood loss, or recovery from anemia 2
  • Polychromasia is a normal compensatory response when the bone marrow is trying to replace lost or destroyed red cells 3
  • The presence of polychromatic cells suggests your bone marrow is functioning and responding appropriately to anemia 4

Anisochromasia

  • Anisochromasia means there is variation in the color intensity of red blood cells on the film - some cells appear darker (more hemoglobin) while others appear paler (less hemoglobin) 1
  • This finding suggests a mixed population of red cells, which can occur during recovery from anemia, iron deficiency with recent treatment, or dimorphic anemias 1

Poikilocytes (Few)

  • Poikilocytes are abnormally shaped red blood cells 5
  • A few poikilocytes can be nonspecific and found in many conditions, but when one specific type dominates, it points toward particular diagnoses 5
  • Common poikilocyte types include teardrop cells (myelofibrosis), spherocytes (hereditary spherocytosis or immune hemolysis), sickle cells (sickle cell disease), and target cells (liver disease, hemoglobinopathies) 1, 5

Clinical Significance and Next Steps

What This Pattern Suggests

  • The combination of polychromasia with anisochromasia and few poikilocytes most commonly indicates:
    • Active hemolysis with adequate bone marrow compensation 3, 2
    • Recent or ongoing blood loss with marrow response 4
    • Recovery phase from anemia (nutritional deficiency being treated, recent bleeding episode) 4
    • Hemoglobinopathies such as sickle cell disease or thalassemia 6, 2

Essential Follow-Up Testing

  • Reticulocyte count is the single most important next test - it quantifies the young red cells suggested by polychromasia and determines if bone marrow response is appropriate 4
  • Complete blood count with indices (MCV, MCH, MCHC) to classify the anemia type 4
  • Peripheral blood smear review by a hematopathologist to identify specific poikilocyte types and other morphologic abnormalities 7, 1
  • Iron studies (ferritin, transferrin saturation) to exclude iron deficiency or overload 1, 4
  • Hemolysis markers if hemolytic anemia suspected: LDH, haptoglobin, indirect bilirubin 1

Specific Diagnostic Considerations

  • If reticulocyte count is elevated (>2-3%), this confirms active red cell production and suggests hemolysis, blood loss, or hemoglobinopathy 4, 3
  • If reticulocyte count is low or normal, this indicates inadequate bone marrow response and suggests nutritional deficiency, bone marrow failure, or anemia of chronic disease 4
  • The type of poikilocytes present is diagnostically important - request specific identification from the laboratory 1, 5

Common Clinical Scenarios

Hemolytic Anemia with Compensation

  • Polychromasia reflects increased reticulocyte production to compensate for shortened red cell survival 3, 2
  • Consider hereditary spherocytosis, G6PD deficiency, pyruvate kinase deficiency, or autoimmune hemolytic anemia 3, 2
  • Check for splenomegaly, jaundice, and family history 3

Post-Hemorrhagic Anemia

  • Polychromasia appears 3-5 days after acute blood loss as the marrow responds 4
  • Anisochromasia may reflect iron deficiency developing from chronic blood loss 1

Myelodysplastic Syndrome (MDS)

  • Poikilocytosis, polychromasia, and anisocytosis are recognized dysplastic features in MDS 1
  • However, MDS typically shows inadequate reticulocyte response (low count despite anemia) 1
  • Consider MDS if cytopenias persist >4 months with dysplastic features 1

Critical Pitfalls to Avoid

  • Do not assume polychromasia means the patient is recovering - it could indicate ongoing hemolysis requiring urgent treatment 3
  • Do not ignore "a few poikilocytes" - ask the laboratory to specify which types are present, as this guides diagnosis 5, 1
  • Do not interpret reticulocyte count in isolation - a "normal" count may be inappropriately low in a severely anemic patient 4
  • Do not miss lead poisoning, which can present with polychromasia, anisocytosis, and basophilic stippling 8
  • Do not forget to check iron studies even in hemolytic anemia, as chronic hemolysis can cause iron overload 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia.

International journal of laboratory hematology, 2018

Guideline

Compensated Hemolysis with Adequate Bone Marrow Response

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Reticulocyte Count in Anemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Blood film features of sickle cell-haemoglobin C disease.

British journal of haematology, 1993

Research

Approach to peripheral blood film assessment for pathologists.

Seminars in diagnostic pathology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.